Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

7.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.6K

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Totarol loaded lipase-responsive liposomes for anti Gram-positive bacterium infection.

RSC advances·2026
Same author

Tumor Immune Microenvironment and Clinicopathological Characteristics of Thoracic NUT Carcinoma.

Laboratory investigation; a journal of technical methods and pathology·2026
Same author

Enterococcus faecalis NBRC 100481 Protects the Intestinal Barrier via α-catenin/HMP-1 in Caenorhabditis elegans.

Probiotics and antimicrobial proteins·2026
Same author

The moderating role of anti-inflammatory diet on the relationship between chronic obstructive pulmonary disease and frailty in older adults: a nationwide cross-sectional and longitudinal study.

BMC geriatrics·2026
Same author

A cold-induced GDF15-secreting adipocyte subpopulation regulates energy homeostasis through endocrine signaling.

Cell reports·2026
Same author

Monodisperse Octahedral PbSe Nanocrystals Encased in Eight (111) Facets and Their Orthorhombic Superlattice.

Journal of the American Chemical Society·2026

相关实验视频

Updated: Jul 6, 2025

Enhancing Tumor Content through Tumor Macrodissection
10:04

Enhancing Tumor Content through Tumor Macrodissection

Published on: February 12, 2022

10.0K

针对扩散性大B细胞淋巴瘤治疗的HDAC进行向治疗.

Chunyan Wu1, Qiao Song2, Sophie Gao3

  • 1Department of Hematology, The Affiliated Hospital of Qingdao University, No.16 Jiangsu Road, Qingdao, 266003, Shandong, China.

Scientific reports
|January 3, 2024
PubMed
概括

基因组脱乙酶 (HDACs) 在扩散性大B细胞淋巴瘤 (DLBCL) 中升高. 用奇达米德向HDAC显示出细胞毒性作用,这表明DLBCL患者的潜在治疗策略.

更多相关视频

Genome-wide Analysis of HDAC Inhibitor-mediated Modulation of microRNAs and mRNAs in B Cells Induced to Undergo Class-switch DNA Recombination and Plasma Cell Differentiation
11:06

Genome-wide Analysis of HDAC Inhibitor-mediated Modulation of microRNAs and mRNAs in B Cells Induced to Undergo Class-switch DNA Recombination and Plasma Cell Differentiation

Published on: September 20, 2017

6.2K
Simultaneous Measurement of HDAC1 and HDAC6 Activity in HeLa Cells Using UHPLC-MS
09:20

Simultaneous Measurement of HDAC1 and HDAC6 Activity in HeLa Cells Using UHPLC-MS

Published on: August 10, 2017

8.6K

相关实验视频

Last Updated: Jul 6, 2025

Enhancing Tumor Content through Tumor Macrodissection
10:04

Enhancing Tumor Content through Tumor Macrodissection

Published on: February 12, 2022

10.0K
Genome-wide Analysis of HDAC Inhibitor-mediated Modulation of microRNAs and mRNAs in B Cells Induced to Undergo Class-switch DNA Recombination and Plasma Cell Differentiation
11:06

Genome-wide Analysis of HDAC Inhibitor-mediated Modulation of microRNAs and mRNAs in B Cells Induced to Undergo Class-switch DNA Recombination and Plasma Cell Differentiation

Published on: September 20, 2017

6.2K
Simultaneous Measurement of HDAC1 and HDAC6 Activity in HeLa Cells Using UHPLC-MS
09:20

Simultaneous Measurement of HDAC1 and HDAC6 Activity in HeLa Cells Using UHPLC-MS

Published on: August 10, 2017

8.6K

科学领域:

  • 在瘤学瘤学.
  • 分子生物学分子生物学
  • 遗传学 遗传学 是一个

背景情况:

  • 基因组脱乙酶 (HDACs) 在癌症发育中起作用.
  • 在扩散性大B细胞淋巴瘤 (DLBCL) 中HDACs的具体参与需要进一步阐明.
  • 了解HDACs在DLBCL中的功能对于开发向疗法至关重要.

研究的目的:

  • 研究DLBCL中的HDAC表达,突变状态和临床意义.
  • 评估在DLBCL中HDAC抑制剂奇达胺的治疗潜力.
  • 为DLBCL治疗中针对HDAC提供证据.

主要方法:

  • 对DLBCL中HDACs的癌症基因组图谱转录组数据的生物信息分析.
  • 使用DLBCL细胞系进行体外研究,以评估奇达米德对增殖和亡的影响.
  • 通过RNA测序和西方斑点分析,探索奇达米德的分子机制.

主要成果:

  • 与对照组相比,在DLBCL淋巴结样本中观察到几个HDACs (HDAC1-4,6-9) 的显著更高的表达.
  • 在DLBCL组织中发现HDAC的突变率增加.
  • 奇胺对DLBCL细胞具有剂量依赖的细胞毒性,影响PI3K/AKT和mTOR等关键信号通路.

结论:

  • 包括过度表达和突变在内的HDAC基因变异与DLBCL有关.
  • 奇胺通过诱导细胞毒性和影响DLBCL中的关键细胞通路,显示出治疗潜力.
  • 用诸如奇达米德等抑制剂向HDAC代表了DLBCL患者有前途的治疗途径.